Vereinigte Staaten Healthcare Sector – Insider-Handelsaktivität

Verfolgen Sie Insider-Käufe und -Verkäufe bei Vereinigte Staaten Healthcare-Aktien. Sehen Sie, welche Führungskräfte kaufen, die Netto-Inside-Aktivität und % des gehandelten Free Floats über 2,070 Unternehmen.
Die in diesem Screen bereitgestellten Informationen dienen nur zu Informationszwecken und stellen keine Finanzberatung dar. Wir befürworten keine spezifische Investition basierend auf diesen Kriterien.
Unternehmen
Daten
Abonnieren, um auf vollständige Daten zuzugreifen
Unternehmen Geschäftsfeld Marktkapitalisierung ($) # Insidern mit Nettokäufen Nettowert gekauft ($) % des Streubesitzes gekauft % der von Insidern gehaltenen Aktien
Pharmaceuticals & Medical Research Mega (1.1tn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Mega (614.4bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals & Medical Research Mega (443.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mega (345.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (333.5bn) -1–5 -$10M–$100M -0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals & Medical Research Mega (230.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mega (221.7bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (188.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (171.6bn) 0 Keine Aktivität — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals & Medical Research Large (155.3bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Large (143.8bn) 0 Keine Aktivität — 0–15%
US Danaher Corp (DHR)
Healthcare Services Large (140.4bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (137.3bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (132.4bn) 0 Keine Aktivität — 0–15%
US Stryker Corp (SYK)
Healthcare Services Large (127.2bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Large (119.9bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (111.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (107.4bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (96.7bn) 0 Keine Aktivität — 15–50%
Pharmaceuticals & Medical Research Large (83.4bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (81.9bn) 0 $1M–$10M 0–15% 0–15%
US Celgene Corp (CELG)
Pharmaceuticals & Medical Research Large (77.0bn) 0 Keine Aktivität — —
Healthcare Services Large (72.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (69.5bn) 1–5 $1M–$10M 0–15% 0–15%
US Allergan plc (AGN)
Pharmaceuticals & Medical Research Large (63.7bn) 0 Keine Aktivität — 0–15%
US Cencora Inc (COR)
Healthcare Services Large (61.7bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Large (53.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (49.2bn) -1–5 -$1M–$10M -0–15% 0–15%
US Medline Inc (MDLN)
Healthcare Services Large (45.6bn) -1–5 -$100M+ -15–50% 0–15%
Pharmaceuticals & Medical Research Large (45.4bn) 0 Keine Aktivität — 0–15%
US Humana Inc (HUM)
Healthcare Services Large (45.0bn) 0 Keine Aktivität — 0–15%
US Seagen Inc (SGEN)
Pharmaceuticals & Medical Research Large (43.2bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (43.1bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (41.0bn) -1–5 -$10M–$100M -0–15% 0–15%
US Waters Corp (WAT)
Healthcare Services Large (40.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (39.2bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (38.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (38.3bn) 0 Keine Aktivität — 0–15%
US DexCom Inc (DXCM)
Healthcare Services Large (34.3bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (33.4bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (32.9bn) 0 Keine Aktivität — 0–15%
US Resmed Inc (RMD)
Healthcare Services Large (32.4bn) 0 Keine Aktivität — 0–15%
US Centene Corp (CNC)
Healthcare Services Large (32.2bn) -1–5 -$10M–$100M -0–15% 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals & Medical Research Large (31.4bn) -1–5 -$100K–$1M -0–15% 0–15%
US Illumina Inc (ILMN)
Healthcare Services Large (31.0bn) -1–5 -$100M+ -0–15% 0–15%
US Zoetis Inc (ZTS)
Pharmaceuticals & Medical Research Large (30.6bn) 0 Keine Aktivität — 0–15%
US Cerner Corp (CERN)
Healthcare Services Large (27.9bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (26.6bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (26.2bn) -6–10 -$100M+ -0–15% 15–50%
Healthcare Services Large (26.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (26.1bn) 0 Keine Aktivität — 0–15%
US Moderna Inc (MRNA)
Pharmaceuticals & Medical Research Large (25.1bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (24.7bn) 0 Keine Aktivität — 0–15%
US Incyte Corp (INCY)
Pharmaceuticals & Medical Research Large (24.5bn) -1–5 -$10M–$100M -0–15% 0–15%
US Steris Ltd (STE)
Healthcare Services Large (23.9bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (21.9bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (21.7bn) -11–20 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (21.6bn) -6–10 -$10M–$100M -0–15% 0–15%
US Insmed Inc (INSM)
Pharmaceuticals & Medical Research Large (21.5bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (20.3bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (20.0bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (18.8bn) -1–5 -$100K–$1M -0–15% 0–15%
US Viatris Inc (VTRS)
Pharmaceuticals & Medical Research Large (18.6bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (18.2bn) 0 Keine Aktivität — 0–15%
US ABIOMED Inc (ABMD)
Healthcare Services Large (17.2bn) 0 Keine Aktivität — 0–15%
US Hologic Inc (HOLX)
Healthcare Services Large (16.9bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (16.3bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (15.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (15.6bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (14.8bn) 0 Keine Aktivität — 15–50%
Pharmaceuticals & Medical Research Large (14.0bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (13.8bn) -1–5 -$100M+ -15–50% 0–15%
Pharmaceuticals & Medical Research Large (13.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US Exelixis Inc (EXEL)
Pharmaceuticals & Medical Research Large (13.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (13.3bn) 0 Keine Aktivität — 0–15%
US Revvity Inc (RVTY)
Healthcare Services Large (13.3bn) 0 Keine Aktivität — 0–15%
US Penumbra Inc (PEN)
Healthcare Services Large (12.8bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (12.6bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (12.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (12.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (12.2bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (12.1bn) -1–5 -$1M–$10M -0–15% 0–15%
US MyoKardia Inc (MYOK)
Pharmaceuticals & Medical Research Large (12.0bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (11.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (11.9bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (11.7bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (11.7bn) 0 Keine Aktivität — 0–15%
US Insulet Corp (PODD)
Healthcare Services Large (11.6bn) 1–5 $100K–$1M 0–15% 0–15%
US Catalent Inc (CTLT)
Pharmaceuticals & Medical Research Large (11.5bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (11.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US DaVita Inc (DVA)
Healthcare Services Large (11.3bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (11.3bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (11.0bn) 1–5 $100K–$1M 0–15% 0–15%
US Glaukos Corp (GKOS)
Healthcare Services Large (11.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) 0 Keine Aktivität — 15–50%
Healthcare Services Large (10.6bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (10.5bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.4bn) 1–5 $100M+ 0–15% 50%+
Pharmaceuticals & Medical Research Large (10.3bn) 0 Keine Aktivität — 0–15%